3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide

C112H106F3N29O7 — CID 158247940

About 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide

3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide (PubChem CID 158247940) has the molecular formula C112H106F3N29O7 and a molecular weight of 2027.27 g/mol. Its IUPAC name is 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide.

Molecular Properties

• Compound Name: 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide
• PubChem CID: 158247940
• Molecular Formula: C112H106F3N29O7
• Molecular Weight: 2027.27 g/mol
• Exact Mass: 2025.88
• IUPAC Name: 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide
• SMILES: Cc1nnc(-c2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)o1.Fc1ccc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)cc1.Fc1ccc(-c2n[nH]c3ccc(CCCCCN4CCOCC4)cc23)cc1.NC(=O)c1ccc2[nH]nc(-c3cccc(NC(=O)CCN4CCCCC4)c3)c2c1.c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)c1.c1cc2[nH]nc(-c3ccc4c(c3)OCO4)c2cc1-c1nn[nH]n1
• InChI: InChI=1S/C22H26FN3O.C22H24N6O.C22H25N5O2.C16H11FN4O.C15H10FN5.C15H10N6O2/c23-19-8-6-18(7-9-19)22-20-16-17(5-10-21(20)24-25-22)4-2-1-3-11-26-12-14-27-15-13-26;1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21;23-22(29)16-7-8-19-18(14-16)21(26-25-19)15-5-4-6-17(13-15)24-20(28)9-12-27-10-2-1-3-11-27;1-9-18-21-16(22-9)11-4-7-14-13(8-11)15(20-19-14)10-2-5-12(17)6-3-10;16-11-4-1-9(2-5-11)14-12-7-10(15-17-8-18-21-15)3-6-13(12)19-20-14;1-3-11-10(5-9(1)15-18-20-21-19-15)14(17-16-11)8-2-4-12-13(6-8)23-7-22-12/h5-10,16H,1-4,11-15H2,(H,24,25);4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27);4-8,13-14H,1-3,9-12H2,(H2,23,29)(H,24,28)(H,25,26);2-8H,1H3,(H,19,20);1-8H,(H,19,20)(H,17,18,21);1-6H,7H2,(H,16,17)(H,18,19,20,21)
• InChIKey: GGIYFUVWKUIVPG-UHFFFAOYSA-N
• XLogP: 20.46
• TPSA: 467.43 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 25
• Rotatable Bonds: 25
• Heavy Atoms: 151
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2027.27
LogP ≤ 5	20.46
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide?

The IUPAC name of 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide (CID 158247940) is 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide.

What is the SMILES notation for 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide?

The canonical SMILES for 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide is Cc1nnc(-c2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)o1.Fc1ccc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)cc1.Fc1ccc(-c2n[nH]c3ccc(CCCCCN4CCOCC4)cc23)cc1.NC(=O)c1ccc2[nH]nc(-c3cccc(NC(=O)CCN4CCCCC4)c3)c2c1.c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4ncn[nH]4)cc23)c1.c1cc2[nH]nc(-c3ccc4c(c3)OCO4)c2cc1-c1nn[nH]n1.

What is the InChIKey of 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide?

The InChIKey is GGIYFUVWKUIVPG-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26FN3O.C22H24N6O.C22H25N5O2.C16H11FN4O.C15H10FN5.C15H10N6O2/c23-19-8-6-18(7-9-19)22-20-16-17(5-10-21(20)24-25-22)4-2-1-3-11-26-12-14-27-15-13-26;1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21;23-22(29)16-7-8-19-18(14-16)21(26-25-19)15-5-4-6-17(13-15)24-20(28)9-12-27-10-2-1-3-11-27;1-9-18-21-16(22-9)11-4-7-14-13(8-11)15(20-19-14)10-2-5-12(17)6-3-10;16-11-4-1-9(2-5-11)14-12-7-10(15-17-8-18-21-15)3-6-13(12)19-20-14;1-3-11-10(5-9(1)15-18-20-21-19-15)14(17-16-11)8-2-4-12-13(6-8)23-7-22-12/h5-10,16H,1-4,11-15H2,(H,24,25);4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27);4-8,13-14H,1-3,9-12H2,(H2,23,29)(H,24,28)(H,25,26);2-8H,1H3,(H,19,20);1-8H,(H,19,20)(H,17,18,21);1-6H,7H2,(H,16,17)(H,18,19,20,21).

What are the key properties of 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide?

3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide has a molecular weight of 2027.27 g/mol, XLogP of 20.46, 25 rotatable bonds, 11 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(1,3-benzodioxol-5-yl)-5-(2H-tetrazol-5-yl)-1H-indazole;2-[3-(4-fluorophenyl)-1H-indazol-5-yl]-5-methyl-1,3,4-oxadiazole;4-[5-[3-(4-fluorophenyl)-1H-indazol-5-yl]pentyl]morpholine;3-(4-fluorophenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole;3-[3-(3-piperidin-1-ylpropanoylamino)phenyl]-1H-indazole-5-carboxamide is sourced from PubChem (CID 158247940), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).